0001300699-15-000004.txt : 20150616 0001300699-15-000004.hdr.sgml : 20150616 20150616104300 ACCESSION NUMBER: 0001300699-15-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150616 DATE AS OF CHANGE: 20150616 EFFECTIVENESS DATE: 20150616 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kinex Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001300699 IRS NUMBER: 431985966 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-241854 FILM NUMBER: 15933490 BUSINESS ADDRESS: STREET 1: 701 ELLICOTT STREET CITY: BUFFALO STATE: NY ZIP: 14203 BUSINESS PHONE: 716-898-8625 MAIL ADDRESS: STREET 1: 701 ELLICOTT STREET CITY: BUFFALO STATE: NY ZIP: 14203 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC DATE OF NAME CHANGE: 20040817 D 1 primary_doc.xml X0707 D LIVE 0001300699 Kinex Pharmaceuticals, Inc. 701 Ellicott Street Buffalo NY NEW YORK 14203 716-898-8625 DELAWARE Kinex Pharmaceuticals LLC Corporation true Flint Besecker 701 Ellicott Street Buffalo NY NEW YORK 14203 Executive Officer Director Johnson Lau 701 Ellicott Street Buffalo NY NEW YORK 14203 Executive Officer Director Jinn Wu 701 Ellicott Street Buffalo NY NEW YORK 14203 Director Biotechnology Decline to Disclose 06b false 2015-04-04 false true true Stock was issued in connection with an acquisition by the Company. 0 10000016 10000016 0 false 2 0 0 0 false Kinex Pharmaceuticals, Inc. /s/ Flint Besecker Flint Besecker Board Director and Chief Operating Officer 2015-06-16